ESP Pharma specializes in acquiring and enhancing the marketing of approved specialty therapeutics and late-stage development drugs for the acute-care hospital market. They provide therapeutics for high blood pressure and angina, as well as drugs for bone marrow transplants. By offering these specialty pharmaceutical products, ESP Pharma aims to improve outcomes for patients in the acute-care setting.